Ellynne Dec

Ellynne Dec

218 Uris




Teaching and research interest

Ellynne Dec is an actuary specialising in healthcare and pharmaceutical strategy. She is an expert in risk quantification and forecasting, working with sparse information and in a big-data environment. Ms Dec has dedicated her career to working with teams making difficult, high-stakes decisions involving uncertain, often unstructured, outcomes. As a graduate student, she studied Applied Mathematics at Colorado School of Mines, and Decision Analysis and Management Science with Professor Ron Howard at Stanford University. She has worked as a drug development strategist at a global pharmaceutical company, and consults to public and private stakeholders in the international life sciences and health industry. Her recent research has focused on: - Evidence-based analysis of breast cancer screening and recall rates, and the costs of standard screening and follow-up to private insurers in the US - Medicare patients with COPD and their annual patterns of consumption of hospital inpatient and outpatient resources - The potential future impact of new therapies on global treatment trends and long-term prevalence of Hepatitis C - Mechanisms for the UK DOH to incentivise and reward pharmaceutical innovation in the context of a reduced pricing scheme